BRD-Groupe Societe Generale (FRA:76B) Research & Development: €0.0 Mil (TTM As of Mar. 2026)


FRA:76B BRD-Groupe Societe Generale SA FRA:76B
53 GF Score
Price €6.44
GF Value €4.01
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is BRD-Groupe Societe Generale Research & Development?

BRD-Groupe Societe Generale FRA:76B 53 Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:76B with a GF Score™ of 53/100 and a GF Value™ of €4.01 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. BRD-Groupe Societe Generale's Research & Development for the three months ended in Mar. 2026 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil.

BRD-Groupe Societe Generale  (FRA:76B) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BRD-Groupe Societe Generale Research & Development Related Terms

BRD-Groupe Societe Generale Research & Development Historical Data

* Premium members only.

The historical data trend for BRD-Groupe Societe Generale's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BRD-Groupe Societe Generale Research & Development Chart

BRD-Groupe Societe Generale Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BRD-Groupe Societe Generale Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:76B
53GF Score
BRD-Groupe Societe Generale SA FRA:76B
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BRD-Groupe Societe Generale Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
BRD-Groupe Societe Generale (FRA:76B) has a Research & Development of €0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on BRD-Groupe Societe Generale and its competitors.
Is BRD-Groupe Societe Generale's Research & Development too high?
BRD-Groupe Societe Generale's current Research & Development is €0.0 Mil. Overall, BRD-Groupe Societe Generale has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BRD-Groupe Societe Generale's Research & Development compare to PNC and USB?
BRD-Groupe Societe Generale's Research & Development of €0.0 Mil can be compared against companies in the Banks industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Banks company?
A good Research & Development depends on the Banks industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on BRD-Groupe Societe Generale and its competitors. BRD-Groupe Societe Generale's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BRD-Groupe Societe Generale stock overvalued right now?
Based on GuruFocus' analysis, BRD-Groupe Societe Generale (FRA:76B) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.01, compared to a current price of €6.44 — trading 60.6% above its estimated fair value. The current Research & Development is €0.0 Mil. BRD-Groupe Societe Generale's overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For BRD-Groupe Societe Generale (FRA:76B), the current Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BRD-Groupe Societe Generale (FRA:76B) Overvalued in 2026?

Based on GuruFocus' analysis, BRD-Groupe Societe Generale stock appears to be overvalued. The current stock price of €6.44 is trading 60.6% above its estimated GF Value™ of €4.01. GuruFocus considers BRD-Groupe Societe Generale to be Significantly Overvalued.

Key valuation signals for FRA:76B:

  • Research & Development: €0.0 Mil
  • GF Value™: €4.01 vs. price of €6.44 (60.6% above fair value)
  • GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the FRA:76B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BRD-Groupe Societe Generale Business Description

Other Exchanges BRD:Romania
Address 1-7 Ion Mihalache Boulevard, Sector 1, BRD Tower, Bucharest, ROU, 011171
BRD-Groupe Societe Generale SA provides banking products and services to individuals and enterprises. The company's operation format is broken down into two segments: Retail segment which consists of Individuals and Small business and Non-retail segments which include Small and medium enterprises and large corporate. It offers products including saving and deposits, consumer and housing loans, overdrafts, credit card facilities, funds transfer and payment facilities. Majority of the income for the group is derived from Interest, Fee and commission income and Net trading income.
53GF Score

Get the complete analysis for FRA:76B

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.44
Price
€4.01
GF Value